SCHEMBL1917352

SCHEMBL1917352

COC(=O)c1cccc(CC[AsH]c2nc(Nc3ccc(Cl)cc3)ncc2[N+](=O)[O-])c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
POLB P06746 1/20 0.50
MAPK1 P28482 1/20 0.50
STK17A Q9UEE5 1/20 0.42
AURKA O14965 2/20 0.40
GSK3A P49840 2/20 0.40
GSK3B P49841 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MCL1 Q07820 1/20 0.39
PTK2B Q14289 1/20 0.39
CYP4F2 P78329 2/20 0.39
CYP4A11 Q02928 2/20 0.39
P2RX3 P56373 4/20 0.39
RECQL P46063 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3284186 0.84 STK17A (0.58) MAPTPOLBMAPK1STK17AAURKA
SCHEMBL3284190 0.82 MAPT (0.52) MAPTPOLBMAPK1STK17AAURKA
SCHEMBL1916987 0.76 STK17A (0.52) MAPTPOLBMAPK1STK17AAURKA
SCHEMBL1916871 0.72 GSK3B (0.58) MAPTSTK17AAURKAGSK3AGSK3B
SCHEMBL1916586 0.69 STK17A (0.61) STK17AAURKAGSK3AGSK3B
SCHEMBL1917178 0.69 STK17A (0.63) MAPTSTK17AAURKAGSK3AGSK3B
SCHEMBL15227963 0.68 MRGPRX4 (0.66) MAPTMAPK1MEN1KMT2ANPC1
SCHEMBL31237014 0.68 MAPT (0.57) MAPTPOLBMAPK1MEN1KMT2A
SCHEMBL31237109 0.67 MAPT (0.53) MAPTPOLBMAPK1MEN1KMT2A
Phenyl Propionic Acid SCHEMBL3290703 0.67 GSK3B (0.54) MAPTMAPK1STK17AAURKAGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332924-A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2011-06-15 EP disclosed